+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hepatitis C Testing Market: Global Opportunity Analysis and Industry Forecast, 2024-2035

  • PDF Icon

    Report

  • 312 Pages
  • February 2025
  • Region: Global
  • Allied Market Research
  • ID: 6120044
Description Jump to:
The hepatitis C testing market was valued at $1.5 billion in 2023 and is estimated to reach $2.6 billion by 2035, exhibiting a CAGR of 4.9% from 2024 to 2035. Hepatitis C is a viral infection caused by the hepatitis C virus (HCV), primarily targeting the liver and posing a significant risk of progressing to chronic liver disease, cirrhosis, and liver cancer if left untreated. The virus spreads primarily through blood-to-blood contact, commonly occurring due to the sharing of contaminated needles, unsterilized medical equipment, or blood transfusions performed before the widespread implementation of rigorous screening protocols. Given the severe health implications of hepatitis C, early and accurate diagnosis is critical in managing the disease effectively. The diagnostic process for hepatitis C typically begins with antibody tests, which help detect prior exposure to the virus. If the initial antibody test yields a positive result, confirmatory testing is performed using RNA-based assays to determine the presence and concentration of the virus in the bloodstream. Advanced molecular techniques, such as polymerase chain reaction (PCR), play a vital role in confirming an active infection and evaluating the viral load, which is essential for treatment planning and monitoring disease progression.

The prevalence of hepatitis C cases globally has amplified the need for reliable and efficient diagnostic solutions. Hepatitis C remains a major public health challenge, as millions of individuals worldwide suffer from either undiagnosed or untreated infections, thus driving the necessity for advanced diagnostic tools capable of facilitating early detection, enabling prompt medical intervention and improving patient outcomes. Furthermore, technological advancements in molecular diagnostics have significantly enhanced the accuracy, efficiency, and speed of hepatitis C testing, making it possible to detect even minimal traces of the virus in a patient’s blood. These innovations have paved the way for early diagnosis, which is crucial in preventing the disease from progressing to severe liver complications.

A major breakthrough in hepatitis C diagnostics is the introduction of multiplex diagnostic kits, which allow simultaneous detection of multiple infections in a single test. This advancement has proven to be highly beneficial in improving diagnostic efficiency while reducing testing costs and turnaround time. One notable example is Trivitron Healthcare’s Triple H (HIV/HCV/HBV) Multiplex Real-Time PCR Kit, an innovative molecular diagnostic tool designed to detect HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) within a single testing process. The integration of such cutting-edge technology streamlines the diagnostic workflow, minimizing the need for multiple tests and expediting the initiation of treatment. The availability of these advanced diagnostic solutions has improved the accessibility and reliability of hepatitis C testing, ensuring more individuals receive timely and accurate diagnoses.

Another factor contributing to the rise in demand for hepatitis C testing is the increase in number of blood donations. Blood transfusions are an essential medical procedure worldwide, playing a crucial role in saving lives in various medical emergencies. Since hepatitis C is a bloodborne virus, ensuring the safety of donated blood is a top priority for healthcare institutions and regulatory bodies. Rigorous screening measures have been implemented to prevent transmission through blood transfusions, further driving the need for high-precision diagnostic methods. As voluntary blood donation programs continue to gain traction, hospitals and blood banks are increasingly adopting sophisticated testing methodologies to uphold stringent blood safety standards. Thus, the rising hepatitis C cases, continuous advancements in diagnostic technologies, and the adoption of multiplex testing solutions are expected to propel the growth of the hepatitis C testing market. With rise in focus on early detection of hepatitis C disease, infection control, and public health initiatives, the integration of molecular diagnostic tools is expected to continue to enhance disease surveillance and management. The development of innovative diagnostic platforms is projected to be instrumental in strengthening global efforts to control the spread of hepatitis C, ultimately contributing to improved healthcare outcomes and reducing the burden of the disease.

The hepatitis C testing market is segmented into technique, test, end user, and region. On the basis of technique, it is segregated into immunoassay, polymerase chain reaction (PCR), and others. The polymerase chain reaction (PCR) segment is further classified into real time PCR, and other PCR. On the basis of test, it is classified into antibody test, genotype tests, and viral load test. On the basis of end user, it is divided into hospital & diagnostic laboratory, blood banks, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The major companies profiled in the report include Abbott Laboratories, Cosara Diagnostics Pvt Ltd, Meril Life Sciences Pvt. Ltd., Molbio Diagnostics Pvt. Ltd., Qiagen N.V., Trivitron Healthcare, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., and Thermo Fisher Scientific Inc. The key players have adopted product approval, partnership, and product launch as the key strategies for expansion of their product portfolio.

Key Benefits for Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the hepatitis c testing market analysis from 2023 to 2035 to identify the prevailing hepatitis c testing market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the hepatitis c testing market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global hepatitis c testing market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • New Product Development/ Product Matrix of Key Players
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Technique

  • Immunoassay
  • PCR
  • Type
  • Real time PCR
  • Other PCR
  • Other Techniques

By Test

  • Antibody test
  • Genotype tests
  • Viral load test

By End User

  • Hospital and Diagnostic Laboratory
  • Blood Banks
  • Other End Users

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • Qiagen N.V.
  • Abbott Laboratories
  • Cosara Diagnostics Pvt Ltd
  • Hologic, Inc.
  • Molbio Diagnostics Pvt. Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • Trivitron Healthcare

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Presence of prevalence of hepatitis C cases
3.4.1.2. Availability of standard guidelines
3.4.1.3. Growing adoption of point of care testing
3.4.2. Restraints
3.4.2.1. Regulatory challenges and low awareness
3.4.3. Opportunities
3.4.3.1. Technological advancements in hepatitis C testing
CHAPTER 4: HEPATITIS C TESTING MARKET, BY TECHNIQUE
4.1. Overview
4.1.1. Market size and forecast
4.2. Immunoassay
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. PCR
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.3.4. PCR Hepatitis C Testing Market by Type
4.3.4.1. Real time PCR Market size and forecast, by region
4.3.4.2. Other PCR Market size and forecast, by region
4.4. Other Techniques
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: HEPATITIS C TESTING MARKET, BY TEST
5.1. Overview
5.1.1. Market size and forecast
5.2. Antibody test
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Genotype tests
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Viral load test
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: HEPATITIS C TESTING MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospital and Diagnostic Laboratory
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Blood Banks
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Other End Users
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: HEPATITIS C TESTING MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Technique
7.2.2.1. North America PCR Hepatitis C Testing Market by Type
7.2.3. Market size and forecast, by Test
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Technique
7.2.5.1.2. Market size and forecast, by Test
7.2.5.1.3. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Technique
7.2.5.2.2. Market size and forecast, by Test
7.2.5.2.3. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Technique
7.2.5.3.2. Market size and forecast, by Test
7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Technique
7.3.2.1. Europe PCR Hepatitis C Testing Market by Type
7.3.3. Market size and forecast, by Test
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Technique
7.3.5.1.2. Market size and forecast, by Test
7.3.5.1.3. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Technique
7.3.5.2.2. Market size and forecast, by Test
7.3.5.2.3. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Technique
7.3.5.3.2. Market size and forecast, by Test
7.3.5.3.3. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Technique
7.3.5.4.2. Market size and forecast, by Test
7.3.5.4.3. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Technique
7.3.5.5.2. Market size and forecast, by Test
7.3.5.5.3. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Technique
7.3.5.6.2. Market size and forecast, by Test
7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Technique
7.4.2.1. Asia-Pacific PCR Hepatitis C Testing Market by Type
7.4.3. Market size and forecast, by Test
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Technique
7.4.5.1.2. Market size and forecast, by Test
7.4.5.1.3. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Technique
7.4.5.2.2. Market size and forecast, by Test
7.4.5.2.3. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Technique
7.4.5.3.2. Market size and forecast, by Test
7.4.5.3.3. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Market size and forecast, by Technique
7.4.5.4.2. Market size and forecast, by Test
7.4.5.4.3. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Technique
7.4.5.5.2. Market size and forecast, by Test
7.4.5.5.3. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Technique
7.4.5.6.2. Market size and forecast, by Test
7.4.5.6.3. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Technique
7.5.2.1. LAMEA PCR Hepatitis C Testing Market by Type
7.5.3. Market size and forecast, by Test
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Technique
7.5.5.1.2. Market size and forecast, by Test
7.5.5.1.3. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by Technique
7.5.5.2.2. Market size and forecast, by Test
7.5.5.2.3. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by Technique
7.5.5.3.2. Market size and forecast, by Test
7.5.5.3.3. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by Technique
7.5.5.4.2. Market size and forecast, by Test
7.5.5.4.3. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Abbott Laboratories
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.2. Cosara Diagnostics Pvt Ltd
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.3. Meril Life Sciences Pvt. Ltd.
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.4. Molbio Diagnostics Pvt. Ltd.
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.5. Qiagen N.V.
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. Trivitron Healthcare
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.7. Bio-Rad Laboratories, Inc.
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.8. F. Hoffmann-La Roche Ltd.
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.8.7. Key strategic moves and developments
9.9. Hologic, Inc.
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.10. Thermo Fisher Scientific Inc.
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
LIST OF TABLES
Table 01. Global Hepatitis C Testing Market, by Technique, 2023-2035 ($Million)
Table 02. Hepatitis C Testing Market for Immunoassay, by Region, 2023-2035 ($Million)
Table 03. Hepatitis C Testing Market for Pcr, by Region, 2023-2035 ($Million)
Table 04. Global Pcr Hepatitis C Testing Market, by Type, 2023-2035 ($Million)
Table 05. Hepatitis C Testing Market for Real Time Pcr, by Region, 2023-2035 ($Million)
Table 06. Hepatitis C Testing Market for Other Pcr, by Region, 2023-2035 ($Million)
Table 07. Hepatitis C Testing Market for Other Techniques, by Region, 2023-2035 ($Million)
Table 08. Global Hepatitis C Testing Market, by Test, 2023-2035 ($Million)
Table 09. Hepatitis C Testing Market for Antibody Test, by Region, 2023-2035 ($Million)
Table 10. Hepatitis C Testing Market for Genotype Tests, by Region, 2023-2035 ($Million)
Table 11. Hepatitis C Testing Market for Viral Load Test, by Region, 2023-2035 ($Million)
Table 12. Global Hepatitis C Testing Market, by End-user, 2023-2035 ($Million)
Table 13. Hepatitis C Testing Market for Hospital and Diagnostic Laboratory, by Region, 2023-2035 ($Million)
Table 14. Hepatitis C Testing Market for Blood Banks, by Region, 2023-2035 ($Million)
Table 15. Hepatitis C Testing Market for Other End-users, by Region, 2023-2035 ($Million)
Table 16. Hepatitis C Testing Market, by Region, 2023-2035 ($Million)
Table 17. North America Hepatitis C Testing Market, by Technique, 2023-2035 ($Million)
Table 18. North America Pcr Hepatitis C Testing Market, by Type, 2023-2035 ($Million)
Table 19. North America Hepatitis C Testing Market, by Test, 2023-2035 ($Million)
Table 20. North America Hepatitis C Testing Market, by End-user, 2023-2035 ($Million)
Table 21. North America Hepatitis C Testing Market, by Country, 2023-2035 ($Million)
Table 22. U.S. Hepatitis C Testing Market, by Technique, 2023-2035 ($Million)
Table 23. U.S. Hepatitis C Testing Market, by Test, 2023-2035 ($Million)
Table 24. U.S. Hepatitis C Testing Market, by End-user, 2023-2035 ($Million)
Table 25. Canada Hepatitis C Testing Market, by Technique, 2023-2035 ($Million)
Table 26. Canada Hepatitis C Testing Market, by Test, 2023-2035 ($Million)
Table 27. Canada Hepatitis C Testing Market, by End-user, 2023-2035 ($Million)
Table 28. Mexico Hepatitis C Testing Market, by Technique, 2023-2035 ($Million)
Table 29. Mexico Hepatitis C Testing Market, by Test, 2023-2035 ($Million)
Table 30. Mexico Hepatitis C Testing Market, by End-user, 2023-2035 ($Million)
Table 31. Europe Hepatitis C Testing Market, by Technique, 2023-2035 ($Million)
Table 32. Europe Pcr Hepatitis C Testing Market, by Type, 2023-2035 ($Million)
Table 33. Europe Hepatitis C Testing Market, by Test, 2023-2035 ($Million)
Table 34. Europe Hepatitis C Testing Market, by End-user, 2023-2035 ($Million)
Table 35. Europe Hepatitis C Testing Market, by Country, 2023-2035 ($Million)
Table 36. Germany Hepatitis C Testing Market, by Technique, 2023-2035 ($Million)
Table 37. Germany Hepatitis C Testing Market, by Test, 2023-2035 ($Million)
Table 38. Germany Hepatitis C Testing Market, by End-user, 2023-2035 ($Million)
Table 39. France Hepatitis C Testing Market, by Technique, 2023-2035 ($Million)
Table 40. France Hepatitis C Testing Market, by Test, 2023-2035 ($Million)
Table 41. France Hepatitis C Testing Market, by End-user, 2023-2035 ($Million)
Table 42. UK Hepatitis C Testing Market, by Technique, 2023-2035 ($Million)
Table 43. UK Hepatitis C Testing Market, by Test, 2023-2035 ($Million)
Table 44. UK Hepatitis C Testing Market, by End-user, 2023-2035 ($Million)
Table 45. Italy Hepatitis C Testing Market, by Technique, 2023-2035 ($Million)
Table 46. Italy Hepatitis C Testing Market, by Test, 2023-2035 ($Million)
Table 47. Italy Hepatitis C Testing Market, by End-user, 2023-2035 ($Million)
Table 48. Spain Hepatitis C Testing Market, by Technique, 2023-2035 ($Million)
Table 49. Spain Hepatitis C Testing Market, by Test, 2023-2035 ($Million)
Table 50. Spain Hepatitis C Testing Market, by End-user, 2023-2035 ($Million)
Table 51. Rest of Europe Hepatitis C Testing Market, by Technique, 2023-2035 ($Million)
Table 52. Rest of Europe Hepatitis C Testing Market, by Test, 2023-2035 ($Million)
Table 53. Rest of Europe Hepatitis C Testing Market, by End-user, 2023-2035 ($Million)
Table 54. Asia-Pacific Hepatitis C Testing Market, by Technique, 2023-2035 ($Million)
Table 55. Asia-Pacific Pcr Hepatitis C Testing Market, by Type, 2023-2035 ($Million)
Table 56. Asia-Pacific Hepatitis C Testing Market, by Test, 2023-2035 ($Million)
Table 57. Asia-Pacific Hepatitis C Testing Market, by End-user, 2023-2035 ($Million)
Table 58. Asia-Pacific Hepatitis C Testing Market, by Country, 2023-2035 ($Million)
Table 59. Japan Hepatitis C Testing Market, by Technique, 2023-2035 ($Million)
Table 60. Japan Hepatitis C Testing Market, by Test, 2023-2035 ($Million)
Table 61. Japan Hepatitis C Testing Market, by End-user, 2023-2035 ($Million)
Table 62. China Hepatitis C Testing Market, by Technique, 2023-2035 ($Million)
Table 63. China Hepatitis C Testing Market, by Test, 2023-2035 ($Million)
Table 64. China Hepatitis C Testing Market, by End-user, 2023-2035 ($Million)
Table 65. India Hepatitis C Testing Market, by Technique, 2023-2035 ($Million)
Table 66. India Hepatitis C Testing Market, by Test, 2023-2035 ($Million)
Table 67. India Hepatitis C Testing Market, by End-user, 2023-2035 ($Million)
Table 68. Australia Hepatitis C Testing Market, by Technique, 2023-2035 ($Million)
Table 69. Australia Hepatitis C Testing Market, by Test, 2023-2035 ($Million)
Table 70. Australia Hepatitis C Testing Market, by End-user, 2023-2035 ($Million)
Table 71. South Korea Hepatitis C Testing Market, by Technique, 2023-2035 ($Million)
Table 72. South Korea Hepatitis C Testing Market, by Test, 2023-2035 ($Million)
Table 73. South Korea Hepatitis C Testing Market, by End-user, 2023-2035 ($Million)
Table 74. Rest of Asia-Pacific Hepatitis C Testing Market, by Technique, 2023-2035 ($Million)
Table 75. Rest of Asia-Pacific Hepatitis C Testing Market, by Test, 2023-2035 ($Million)
Table 76. Rest of Asia-Pacific Hepatitis C Testing Market, by End-user, 2023-2035 ($Million)
Table 77. LAMEA Hepatitis C Testing Market, by Technique, 2023-2035 ($Million)
Table 78. LAMEA Pcr Hepatitis C Testing Market, by Type, 2023-2035 ($Million)
Table 79. LAMEA Hepatitis C Testing Market, by Test, 2023-2035 ($Million)
Table 80. LAMEA Hepatitis C Testing Market, by End-user, 2023-2035 ($Million)
Table 81. LAMEA Hepatitis C Testing Market, by Country, 2023-2035 ($Million)
Table 82. Brazil Hepatitis C Testing Market, by Technique, 2023-2035 ($Million)
Table 83. Brazil Hepatitis C Testing Market, by Test, 2023-2035 ($Million)
Table 84. Brazil Hepatitis C Testing Market, by End-user, 2023-2035 ($Million)
Table 85. Saudi Arabia Hepatitis C Testing Market, by Technique, 2023-2035 ($Million)
Table 86. Saudi Arabia Hepatitis C Testing Market, by Test, 2023-2035 ($Million)
Table 87. Saudi Arabia Hepatitis C Testing Market, by End-user, 2023-2035 ($Million)
Table 88. South Africa Hepatitis C Testing Market, by Technique, 2023-2035 ($Million)
Table 89. South Africa Hepatitis C Testing Market, by Test, 2023-2035 ($Million)
Table 90. South Africa Hepatitis C Testing Market, by End-user, 2023-2035 ($Million)
Table 91. Rest of LAMEA Hepatitis C Testing Market, by Technique, 2023-2035 ($Million)
Table 92. Rest of LAMEA Hepatitis C Testing Market, by Test, 2023-2035 ($Million)
Table 93. Rest of LAMEA Hepatitis C Testing Market, by End-user, 2023-2035 ($Million)
Table 94. Abbott Laboratories: Key Executives
Table 95. Abbott Laboratories: Company Snapshot
Table 96. Abbott Laboratories: Product Segments
Table 97. Abbott Laboratories: Product Portfolio
Table 98. Cosara Diagnostics Pvt Ltd: Key Executives
Table 99. Cosara Diagnostics Pvt Ltd: Company Snapshot
Table 100. Cosara Diagnostics Pvt Ltd: Product Segments
Table 101. Cosara Diagnostics Pvt Ltd: Product Portfolio
Table 102. Meril Life Sciences Pvt. Ltd.: Key Executives
Table 103. Meril Life Sciences Pvt. Ltd.: Company Snapshot
Table 104. Meril Life Sciences Pvt. Ltd.: Product Segments
Table 105. Meril Life Sciences Pvt. Ltd.: Product Portfolio
Table 106. Molbio Diagnostics Pvt. Ltd.: Key Executives
Table 107. Molbio Diagnostics Pvt. Ltd.: Company Snapshot
Table 108. Molbio Diagnostics Pvt. Ltd.: Product Segments
Table 109. Molbio Diagnostics Pvt. Ltd.: Product Portfolio
Table 110. Qiagen N.V.: Key Executives
Table 111. Qiagen N.V.: Company Snapshot
Table 112. Qiagen N.V.: Product Segments
Table 113. Qiagen N.V.: Product Portfolio
Table 114. Qiagen N.V.: Key Stratergies
Table 115. Trivitron Healthcare: Key Executives
Table 116. Trivitron Healthcare: Company Snapshot
Table 117. Trivitron Healthcare: Product Segments
Table 118. Trivitron Healthcare: Product Portfolio
Table 119. Bio-Rad Laboratories, Inc. : Key Executives
Table 120. Bio-Rad Laboratories, Inc. : Company Snapshot
Table 121. Bio-Rad Laboratories, Inc. : Product Segments
Table 122. Bio-Rad Laboratories, Inc. : Product Portfolio
Table 123. F. Hoffmann-La Roche Ltd.: Key Executives
Table 124. F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 125. F. Hoffmann-La Roche Ltd.: Product Segments
Table 126. F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 127. F. Hoffmann-La Roche Ltd.: Key Stratergies
Table 128. Hologic, Inc.: Key Executives
Table 129. Hologic, Inc.: Company Snapshot
Table 130. Hologic, Inc.: Product Segments
Table 131. Hologic, Inc.: Product Portfolio
Table 132. Thermo Fisher Scientific Inc.: Key Executives
Table 133. Thermo Fisher Scientific Inc.: Company Snapshot
Table 134. Thermo Fisher Scientific Inc.: Product Segments
Table 135. Thermo Fisher Scientific Inc.: Product Portfolio
LIST OF FIGURES
Figure 01. Hepatitis C Testing Market, 2023-2035
Figure 02. Segmentation of Hepatitis C Testing Market,2023-2035
Figure 03. Top Impacting Factors in Hepatitis C Testing Market (2023 to 2035)
Figure 04. Top Investment Pockets in Hepatitis C Testing Market (2024-2035)
Figure 05. Moderate Bargaining Power of Suppliers
Figure 06. Moderate Threat of New Entrants
Figure 07. Moderate Threat of Substitutes
Figure 08. Moderate Intensity of Rivalry
Figure 09. Moderate Bargaining Power of Buyers
Figure 10. Global Hepatitis C Testing Market:Drivers, Restraints and Opportunities
Figure 11. Hepatitis C Testing Market, by Technique, 2023 and 2035(%)
Figure 12. Comparative Share Analysis of Hepatitis C Testing Market for Immunoassay, by Country 2023 and 2035(%)
Figure 13. Comparative Share Analysis of Hepatitis C Testing Market for Pcr, by Country 2023 and 2035(%)
Figure 14. Comparative Share Analysis of Hepatitis C Testing Market for Other Techniques, by Country 2023 and 2035(%)
Figure 15. Hepatitis C Testing Market, by Test, 2023 and 2035(%)
Figure 16. Comparative Share Analysis of Hepatitis C Testing Market for Antibody Test, by Country 2023 and 2035(%)
Figure 17. Comparative Share Analysis of Hepatitis C Testing Market for Genotype Tests, by Country 2023 and 2035(%)
Figure 18. Comparative Share Analysis of Hepatitis C Testing Market for Viral Load Test, by Country 2023 and 2035(%)
Figure 19. Hepatitis C Testing Market, by End-user, 2023 and 2035(%)
Figure 20. Comparative Share Analysis of Hepatitis C Testing Market for Hospital and Diagnostic Laboratory, by Country 2023 and 2035(%)
Figure 21. Comparative Share Analysis of Hepatitis C Testing Market for Blood Banks, by Country 2023 and 2035(%)
Figure 22. Comparative Share Analysis of Hepatitis C Testing Market for Other End-users, by Country 2023 and 2035(%)
Figure 23. Hepatitis C Testing Market by Region, 2023 and 2035(%)
Figure 24. U.S. Hepatitis C Testing Market, 2023-2035 ($Million)
Figure 25. Canada Hepatitis C Testing Market, 2023-2035 ($Million)
Figure 26. Mexico Hepatitis C Testing Market, 2023-2035 ($Million)
Figure 27. Germany Hepatitis C Testing Market, 2023-2035 ($Million)
Figure 28. France Hepatitis C Testing Market, 2023-2035 ($Million)
Figure 29. UK Hepatitis C Testing Market, 2023-2035 ($Million)
Figure 30. Italy Hepatitis C Testing Market, 2023-2035 ($Million)
Figure 31. Spain Hepatitis C Testing Market, 2023-2035 ($Million)
Figure 32. Rest of Europe Hepatitis C Testing Market, 2023-2035 ($Million)
Figure 33. Japan Hepatitis C Testing Market, 2023-2035 ($Million)
Figure 34. China Hepatitis C Testing Market, 2023-2035 ($Million)
Figure 35. India Hepatitis C Testing Market, 2023-2035 ($Million)
Figure 36. Australia Hepatitis C Testing Market, 2023-2035 ($Million)
Figure 37. South Korea Hepatitis C Testing Market, 2023-2035 ($Million)
Figure 38. Rest of Asia-Pacific Hepatitis C Testing Market, 2023-2035 ($Million)
Figure 39. Brazil Hepatitis C Testing Market, 2023-2035 ($Million)
Figure 40. Saudi Arabia Hepatitis C Testing Market, 2023-2035 ($Million)
Figure 41. South Africa Hepatitis C Testing Market, 2023-2035 ($Million)
Figure 42. Rest of LAMEA Hepatitis C Testing Market, 2023-2035 ($Million)
Figure 43. Top Winning Strategies, by Year (2023-2024)
Figure 44. Top Winning Strategies, by Development (2023-2024)
Figure 45. Top Winning Strategies, by Company (2023-2024)
Figure 46. Product Mapping of Top 10 Players
Figure 47. Competitive Dashboard
Figure 48. Competitive Heatmap: Hepatitis C Testing Market
Figure 49. Top Player Positioning, 2023
Figure 50. Abbott Laboratories: Net Revenue, 2021-2023 ($Million)
Figure 51. Abbott Laboratories: Revenue Share by Segment, 2023 (%)
Figure 52. Abbott Laboratories: Revenue Share by Region, 2023 (%)
Figure 53. Qiagen N.V.: Net Revenue, 2021-2023 ($Million)
Figure 54. Qiagen N.V.: Revenue Share by Region, 2023 (%)
Figure 55. Bio-Rad Laboratories, Inc. : Net Sales, 2021-2023 ($Million)
Figure 56. Bio-Rad Laboratories, Inc. : Revenue Share by Segment, 2023 (%)
Figure 57. Bio-Rad Laboratories, Inc. : Revenue Share by Region, 2023 (%)
Figure 58. F. Hoffmann-La Roche Ltd.: Sales Revenue, 2021-2023 ($Million)
Figure 59. F. Hoffmann-La Roche Ltd.: Revenue Share by Segment, 2023 (%)
Figure 60. F. Hoffmann-La Roche Ltd.: Revenue Share by Region, 2023 (%)
Figure 61. Hologic, Inc.: Net Revenue, 2022-2024 ($Million)
Figure 62. Hologic, Inc.: Revenue Share by Segment, 2024 (%)
Figure 63. Hologic, Inc.: Revenue Share by Region, 2024 (%)
Figure 64. Thermo Fisher Scientific Inc.: Net Revenue, 2021-2023 ($Million)
Figure 65. Thermo Fisher Scientific Inc.: Revenue Share by Segment, 2023 (%)
Figure 66. Thermo Fisher Scientific Inc.: Revenue Share by Region, 2023 (%)

Companies Mentioned

  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • Qiagen N.V.
  • Abbott Laboratories
  • Cosara Diagnostics Pvt Ltd
  • Hologic, Inc.
  • Molbio Diagnostics Pvt. Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • Trivitron Healthcare

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Related Topics

Related Reports

Hepatitis D Market - A Global and Regional Analysis: Focus on Treatment Type, Diagnostic Method, and Region - Analysis and Forecast, 2025-2035 - Product Image

Hepatitis D Market - A Global and Regional Analysis: Focus on Treatment Type, Diagnostic Method, and Region - Analysis and Forecast, 2025-2035

  • Report
  • Global
From
Molecular Diagnostics Market Industry Trends and Global Forecasts 2023-2035: Distribution by Product, Technology, Application, Sample Type, End Users and Key Geographical Regions - Product Image

Molecular Diagnostics Market Industry Trends and Global Forecasts 2023-2035: Distribution by Product, Technology, Application, Sample Type, End Users and Key Geographical Regions

  • Report
  • Global
From
Hepatitis C virus (HCV) Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Hepatitis C virus (HCV) Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 190 Pages
  • Global
From
Hepatitis C Testing Global Market Report 2025 - Product Image

Hepatitis C Testing Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Hepatitis Test Solution/Diagnosis - Global Strategic Business Report - Product Image

Hepatitis Test Solution/Diagnosis - Global Strategic Business Report

  • Report
  • 275 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.